Complete financial analysis of Walgreens Boots Alliance, Inc. (WBA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Walgreens Boots Alliance, Inc., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- KC Green Holdings Co., Ltd. (009440.KS) Income Statement Analysis – Financial Results
- Travel + Leisure Co. (0M1K.L) Income Statement Analysis – Financial Results
- Beekay Steel Industries Limited (BEEKAY.BO) Income Statement Analysis – Financial Results
- FLSmidth & Co. A/S (FLIDF) Income Statement Analysis – Financial Results
- Osang Healthcare Co.,Ltd (036220.KQ) Income Statement Analysis – Financial Results
Walgreens Boots Alliance, Inc. (WBA)
Industry: Medical - Pharmaceuticals
Sector: Healthcare
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 147.66B | 139.08B | 132.70B | 132.51B | 121.98B | 120.07B | 131.54B | 118.21B | 117.35B | 103.44B | 76.39B | 72.22B | 71.63B | 72.18B | 67.42B | 63.34B | 59.03B | 53.76B | 47.41B | 42.20B | 37.51B | 32.51B | 28.68B | 24.62B | 21.21B | 17.84B | 15.31B | 13.36B | 11.78B | 10.40B | 9.24B | 8.29B | 7.48B | 6.73B | 6.05B | 5.38B | 4.88B | 4.28B | 3.66B | 3.16B |
| Cost of Revenue | 121.13B | 112.01B | 104.44B | 104.44B | 95.91B | 91.92B | 100.75B | 89.05B | 87.48B | 76.59B | 54.82B | 51.10B | 51.29B | 51.69B | 48.44B | 45.72B | 42.39B | 38.52B | 34.24B | 30.41B | 27.31B | 23.71B | 21.08B | 18.05B | 15.24B | 12.77B | 10.95B | 9.52B | 8.37B | 7.35B | 6.50B | 5.85B | 5.29B | 4.74B | 4.29B | 3.78B | 3.41B | 2.95B | 2.51B | 2.16B |
| Gross Profit | 26.52B | 27.07B | 28.27B | 28.07B | 26.08B | 28.16B | 30.79B | 29.16B | 29.87B | 26.86B | 21.57B | 21.12B | 20.34B | 20.49B | 18.98B | 17.61B | 16.64B | 15.24B | 13.17B | 11.79B | 10.20B | 8.80B | 7.61B | 6.57B | 5.97B | 5.07B | 4.36B | 3.85B | 3.41B | 3.04B | 2.74B | 2.44B | 2.19B | 1.99B | 1.76B | 1.60B | 1.47B | 1.33B | 1.15B | 1.00B |
| Gross Profit Ratio | 17.96% | 19.46% | 21.30% | 21.18% | 21.38% | 23.45% | 23.41% | 24.67% | 25.46% | 25.96% | 28.23% | 29.24% | 28.40% | 28.39% | 28.15% | 27.81% | 28.19% | 28.35% | 27.78% | 27.93% | 27.19% | 27.07% | 26.52% | 26.70% | 28.16% | 28.42% | 28.46% | 28.77% | 28.96% | 29.29% | 29.66% | 29.42% | 29.29% | 29.53% | 29.13% | 29.65% | 30.18% | 31.16% | 31.54% | 31.75% |
| Research & Development | 0.00 | 371.00M | 307.00M | 284.00M | 300.00M | 260.00M | 254.00M | 245.00M | 238.00M | 178.00M | 127.00M | 105.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 25.62B | 24.70B | 24.13B | 23.03B | 22.30B | 22.60B | 23.97B | 23.05B | 22.83B | 21.18B | 17.43B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 694.00M | 775.00M | 862.00M | 772.00M | 532.00M | 582.00M | 665.00M | 571.00M | 598.00M | 491.00M | 265.00M | 286.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 28.11B | 25.48B | 24.99B | 23.80B | 22.84B | 23.18B | 24.64B | 23.62B | 23.43B | 21.67B | 17.69B | 17.47B | 16.88B | 16.56B | 15.52B | 14.37B | 13.20B | 12.09B | 10.47B | 9.36B | 8.06B | 6.95B | 5.98B | 5.18B | 4.52B | 3.84B | 3.33B | 2.97B | 2.66B | 2.39B | 2.16B | 1.93B | 1.74B | 1.58B | 1.41B | 1.28B | 1.19B | 1.07B | 914.00M | 791.70M |
| Other Expenses | 0.00 | 8.10B | 1.58B | 1.64B | 1.96B | -50.00M | -389.00M | -185.00M | 210.00M | 344.00M | -443.00M | 0.00 | 0.00 | -434.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 230.10M | 210.10M | 189.00M | 164.00M | 147.30M | 131.50M | 118.10M | 104.70M | 92.10M | 84.30M | 70.40M | 63.80M | 59.40M | 53.70M | 43.80M | 34.40M |
| Operating Expenses | 40.60B | 33.95B | 26.88B | 25.73B | 25.10B | 23.39B | 24.50B | 23.68B | 23.87B | 22.19B | 17.38B | 16.98B | 16.88B | 16.13B | 15.52B | 14.37B | 13.20B | 12.09B | 10.47B | 9.36B | 8.06B | 6.95B | 5.98B | 5.18B | 4.75B | 4.05B | 3.52B | 3.14B | 2.81B | 2.52B | 2.28B | 2.03B | 1.83B | 1.67B | 1.48B | 1.34B | 1.25B | 1.12B | 957.80M | 826.10M |
| Cost & Expenses | 161.73B | 145.96B | 131.32B | 130.17B | 121.00B | 115.31B | 125.25B | 112.73B | 111.35B | 98.78B | 72.20B | 68.08B | 68.17B | 67.82B | 63.96B | 60.09B | 55.59B | 50.61B | 44.71B | 39.78B | 35.37B | 30.66B | 27.06B | 23.22B | 19.98B | 16.82B | 14.47B | 12.66B | 11.17B | 9.88B | 8.78B | 7.89B | 7.12B | 6.41B | 5.76B | 5.13B | 4.66B | 4.07B | 3.46B | 2.98B |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 29.00M | 0.00 | 0.00 | 0.00 | 0.00 | 134.00M | 0.00 | 95.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 482.00M | 580.00M | 396.00M | 491.00M | 613.00M | 650.00M | 616.00M | 693.00M | 596.00M | 605.00M | 156.00M | 165.00M | 88.00M | 71.00M | 85.00M | 83.00M | 11.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 2.46B | 1.89B | 1.68B | 1.69B | 1.63B | 1.78B | 1.52B | 1.41B | 1.48B | 1.56B | 1.21B | 1.18B | 1.17B | 1.09B | 1.03B | 975.00M | 840.00M | 675.90M | 572.20M | 482.10M | 403.10M | 346.10M | 307.30M | 269.20M | 230.10M | 210.10M | 189.00M | 164.00M | 147.30M | 131.50M | 118.10M | 104.70M | 92.10M | 84.30M | 70.40M | 63.80M | 59.40M | 53.70M | 43.80M | 34.40M |
| EBITDA | -11.28B | 3.48B | 4.96B | 5.96B | 2.84B | 6.75B | 7.67B | 6.95B | 7.93B | 6.75B | 5.08B | 5.34B | 4.63B | 5.45B | 4.49B | 4.22B | 4.28B | 3.83B | 3.27B | 2.91B | 2.55B | 2.21B | 1.93B | 1.67B | 1.45B | 1.23B | 1.02B | 872.60M | 751.40M | 651.60M | 573.80M | 510.90M | 450.60M | 405.50M | 354.60M | 317.30M | 283.60M | 264.40M | 240.40M | 212.20M |
| EBITDA Ratio | -7.64% | -1.86% | 4.80% | 4.12% | 2.37% | 5.31% | 6.36% | 6.09% | 6.36% | 7.40% | 6.58% | 7.37% | 6.46% | 7.55% | 6.66% | 6.67% | 7.25% | 7.12% | 6.91% | 6.89% | 6.74% | 6.66% | 6.71% | 6.68% | 6.70% | 6.87% | 6.45% | 6.48% | 6.34% | 6.22% | 6.15% | 6.16% | 5.89% | 5.89% | 5.61% | 5.73% | 5.72% | 6.15% | 6.51% | 6.65% |
| Operating Income | -14.08B | -6.88B | 1.39B | 2.34B | 982.00M | 4.77B | 6.29B | 5.48B | 6.00B | 4.67B | 4.19B | 3.65B | 3.46B | 4.37B | 3.46B | 3.25B | 3.44B | 3.15B | 2.70B | 2.42B | 2.14B | 1.85B | 1.62B | 1.40B | 1.22B | 1.02B | 835.00M | 708.00M | 604.10M | 520.10M | 455.70M | 406.20M | 358.50M | 321.20M | 284.20M | 253.50M | 224.20M | 210.70M | 196.60M | 177.80M |
| Operating Income Ratio | -9.53% | -4.95% | 1.05% | 1.77% | 0.81% | 3.97% | 4.78% | 4.64% | 5.11% | 4.51% | 5.49% | 5.05% | 4.84% | 6.05% | 5.13% | 5.13% | 5.83% | 5.86% | 5.70% | 5.74% | 5.71% | 5.69% | 5.66% | 5.68% | 5.77% | 5.69% | 5.46% | 5.30% | 5.13% | 5.00% | 4.93% | 4.90% | 4.80% | 4.77% | 4.70% | 4.71% | 4.59% | 4.92% | 5.37% | 5.62% |
| Total Other Income/Expenses | -126.00M | 1.46B | 2.65B | 280.00M | -505.00M | -399.00M | -260.00M | -623.00M | -813.00M | 667.00M | -637.00M | -45.00M | -88.00M | -71.00M | -85.00M | -83.00M | -11.00M | 28.80M | 52.60M | -11.30M | 17.00M | 23.40M | 13.10M | 24.40M | 39.20M | 11.90M | 42.10M | 4.60M | 2.80M | 3.70M | 2.70M | -6.50M | -5.50M | -9.20M | -3.30M | -9.70M | -15.20M | -16.60M | -9.00M | -4.10M |
| Income Before Tax | -14.20B | -5.39B | 4.04B | 2.62B | 477.00M | 4.37B | 6.03B | 4.86B | 5.19B | 5.34B | 3.56B | 4.05B | 3.38B | 4.29B | 3.37B | 3.16B | 3.43B | 3.19B | 2.75B | 2.46B | 2.18B | 1.89B | 1.64B | 1.42B | 1.26B | 1.03B | 877.00M | 712.00M | 606.90M | 523.80M | 458.40M | 399.70M | 353.00M | 312.00M | 280.90M | 243.80M | 209.00M | 194.10M | 187.60M | 173.70M |
| Income Before Tax Ratio | -9.62% | -3.87% | 3.04% | 1.98% | 0.39% | 3.64% | 4.58% | 4.11% | 4.42% | 5.16% | 4.66% | 5.60% | 4.71% | 5.95% | 5.00% | 5.00% | 5.81% | 5.93% | 5.81% | 5.82% | 5.80% | 5.81% | 5.71% | 5.78% | 5.96% | 5.76% | 5.73% | 5.33% | 5.15% | 5.04% | 4.96% | 4.82% | 4.72% | 4.63% | 4.64% | 4.53% | 4.28% | 4.53% | 5.12% | 5.49% |
| Income Tax Expense | 1.25B | 1.86B | 30.00M | 667.00M | 339.00M | 577.00M | 998.00M | 760.00M | 997.00M | 1.06B | 1.53B | 1.50B | 1.25B | 1.58B | 1.28B | 1.16B | 1.27B | 1.15B | 1.00B | 896.10M | 816.10M | 713.00M | 618.10M | 537.10M | 486.40M | 403.20M | 340.00M | 276.00M | 235.20M | 203.00M | 176.50M | 154.40M | 132.40M | 117.00M | 106.30M | 89.60M | 79.90M | 90.60M | 84.50M | 79.50M |
| Net Income | -8.64B | -3.08B | 4.34B | 2.54B | 456.00M | 3.98B | 5.02B | 4.08B | 4.17B | 4.22B | 1.93B | 2.55B | 2.13B | 2.71B | 2.09B | 2.01B | 2.16B | 2.04B | 1.75B | 1.56B | 1.36B | 1.18B | 1.02B | 885.60M | 776.90M | 624.10M | 511.00M | 436.00M | 371.70M | 320.80M | 281.90M | 221.70M | 220.60M | 195.00M | 174.60M | 154.20M | 129.10M | 103.50M | 103.10M | 94.20M |
| Net Income Ratio | -5.85% | -2.21% | 3.27% | 1.92% | 0.37% | 3.32% | 3.82% | 3.45% | 3.56% | 4.08% | 2.53% | 3.53% | 2.97% | 3.76% | 3.10% | 3.17% | 3.65% | 3.80% | 3.69% | 3.70% | 3.63% | 3.62% | 3.55% | 3.60% | 3.66% | 3.50% | 3.34% | 3.26% | 3.16% | 3.09% | 3.05% | 2.67% | 2.95% | 2.90% | 2.89% | 2.87% | 2.64% | 2.42% | 2.82% | 2.98% |
| EPS | -10.01 | -3.57 | 5.02 | 2.31 | 0.20 | 4.14 | 5.07 | 3.80 | 3.85 | 4.05 | 2.03 | 2.69 | 2.43 | 2.97 | 2.13 | 2.03 | 2.18 | 2.04 | 1.73 | 1.53 | 1.32 | 1.14 | 1.00 | 0.87 | 0.77 | 0.62 | 0.26 | 0.22 | 0.38 | 0.33 | 0.28 | 0.03 | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | -10.01 | -3.57 | 5.01 | 2.30 | 0.20 | 4.13 | 5.05 | 3.78 | 3.82 | 4.00 | 2.00 | 2.67 | 2.42 | 2.94 | 2.12 | 2.02 | 2.17 | 2.03 | 1.72 | 1.52 | 1.31 | 1.13 | 0.99 | 0.86 | 0.76 | 0.62 | 0.26 | 0.22 | 0.38 | 0.33 | 0.28 | 0.03 | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Weighted Avg Shares Out | 863.10M | 863.20M | 864.40M | 864.80M | 879.40M | 921.50M | 991.00M | 1.07B | 1.08B | 1.04B | 953.10M | 946.00M | 874.70M | 915.10M | 981.70M | 990.00M | 990.61M | 998.63M | 1.01B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 1.01B | 1.00B | 1.98B | 987.58M | 991.20M | 987.08M | 989.12M | 984.57M | 984.57M | 984.57M | 984.38M | 984.27M | 984.22M | 984.06M | 983.92M | 982.37M |
| Weighted Avg Shares Out (Dil) | 863.10M | 863.20M | 865.90M | 866.40M | 880.30M | 923.50M | 995.00M | 1.08B | 1.09B | 1.05B | 965.20M | 955.20M | 880.10M | 924.50M | 987.90M | 991.30M | 995.54M | 1.01B | 1.02B | 1.03B | 1.03B | 1.03B | 1.03B | 1.03B | 1.02B | 1.01B | 2.01B | 987.58M | 991.20M | 987.08M | 989.12M | 984.57M | 984.57M | 984.57M | 984.38M | 984.27M | 984.22M | 984.06M | 983.92M | 982.37M |
Big Potential Brewing – Will Walgreens Deliver a Rally?
Every once in a while, a major brand name and its stock's existence are challenged. Often, the price action and the threatening state of the company are justified, and the business does end up going under.
Walgreens Boots Alliance Analysts Expect Strategic Plans Will Boost Investor Confidence In 2025
Walgreens Boots Alliance Inc (NASDAQ: WBA) reported fourth-quarter fiscal year 2024 sales of $37.55 billion on Tuesday.
WBA Stock Up 16% on New Restructuring Strategy: How to Play the Stock
Walgreens Boots is currently going all out to reform its pharmacy model by aggressively liquidating its unprofitable stores and businesses.
Walgreens plans to close 1,200 stores, with 500 locations shuttering in the next year
Walgreens is targeting to close approximately 1,200 stores over the next three years, with 500 of those closures happening in the 2025 fiscal year, the drugstore company told Fast Company.
1 Wall Street Analyst Thinks Walgreens Boots Alliance Stock Is Going to $16. Is It a Sell?
It isn't easy to be positive on the struggling company's prospects.
Walgreens: A Turnaround Stock To Avoid
Walgreens plans to close 1,200 stores, impacting 13.79% of its total locations, to restructure and improve financial health. Despite beating Wall Street estimates, Walgreens' adjusted operating income fell 38%, and adjusted EPS dropped to $0.39 from $0.67 a year ago....
Walgreens Boots Alliance, Inc. (WBA) Q4 2024 Earnings Call Transcript
Walgreens Boots Alliance, Inc. (NASDAQ:WBA ) Q4 2024 Earnings Call Transcript October 15, 2024 8:30 AM ET Company Participants Tiffany Kanaga - VP of Global IR Tim Wentworth - CEO Manmohan Mahajan - Global CFO Mary Langowski - President, US...
WBA Stock Up on Q4 Earnings & Revenues Beat, Unveils Strategic Action
Walgreens reports better-than-expected earnings and revenues in the fourth quarter of fiscal 2024.
Walgreens Doesn't ‘Count on' Strong Consumer Spend for Q4
Walgreens Boots Alliance is undertaking a transformation focused on its retail pharmacy business in response to persistent challenges in the consumer market and pharmacy sector. As part of this strategy, the company plans to close approximately 1,200 underperforming stores in...
Why Walgreens Boots Alliance Stock Is Skyrocketing Today
Investors are applauding the pharmacy retailer's plan to close many of its unprofitable stores.
Source: https://incomestatements.info
Category: Stock Reports